Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹1000 | ₹100 |
Expense Ratio | 2.12 | 2.27 |
NAV | ₹15.09 | ₹158.35 |
Fund Started | 12 May 2023 | 13 Oct 2005 |
Fund Size | ₹1237.93 Cr | ₹1330.73 Cr |
Exit Load | Exit load of 1%, if redeemed within 15 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -4.30% | 13.59% |
3 Year | - | 21.08% |
5 Year | - | 28.00% |
1 Year
3 Year
5 Year
Equity | 89.95% | 95.64% |
Cash | 5.65% | 3.99% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Reliance Industries Ltd. | 9.93% |
HFCL Ltd. | 6.33% |
Samvardhana Motherson International Ltd. | 5.82% |
JIO Financial Services Ltd. | 5.63% |
Aurobindo Pharma Ltd. | 5.07% |
Larsen & Toubro Ltd. | 4.82% |
S.P. Apparels Ltd. | 4.66% |
Life Insurance Corporation of India | 4.62% |
Alivus Life Sciences Ltd | 4.34% |
Sun TV Network Ltd. | 4.09% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 8.08% |
HDFC Bank Ltd. | 6.24% |
Reliance Industries Ltd. | 6.14% |
Axis Bank Ltd. | 5.79% |
State Bank of India | 5.53% |
NTPC Ltd. | 5.47% |
Infosys Ltd. | 4.92% |
Larsen & Toubro Ltd. | 4.09% |
Bharti Airtel Ltd. | 4.05% |
Sun Pharmaceutical Industries Ltd. | 3.24% |
Name | Ankit A Pande | Sri Sharma |
Start Date | 22 Aug 2023 | 30 Apr 2021 |
Name
Start Date
Description | The scheme seeks to generate long-term capital appreciation by investing with focus on riding business cycles through allocation between sectors and stocks at different stages of business cycles. | The scheme seeks to generate capital appreciation and income distribution to unit holders by investing predominantly in equity/equity related securities of the companies belonging to Exports & Services industry. |
Launch Date | 12 May 2023 | 13 Oct 2005 |
Description
Launch Date